Three Davis Polk matters named “Impact Deal of the Year” at 2026 Life Sciences Americas Awards

Three Davis Polk matters were awarded “Impact Deal of the Year – United States” at the 2026 Life Sciences Americas Awards. The awards celebrate successes in the life sciences industry and honor the leading law firms and attorneys in the space.

The firm was recognized for its role on the following deals:

• Impact Deal of the Year - Aktis Oncology $365 million IPO
• Impact Deal of the Year - GSK agreements with Hengrui Pharma to develop up to 12 innovative medicines
• Impact Deal of the Year - Penumbra $14.5 billion sale to Boston Scientific

The awards were presented on September 10, 2026, in New York.